NCT06069570
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Stage 4 Metastatic NSCLC No drug interventions treatment 1 recruiting NCT05456867
A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in Russia No drug interventions Not Available Not Available recruiting NCT05647122
First in Human Study of AZD9592 in Solid Tumors treatment 1 recruiting NCT01306045
Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies treatment 2 completed NCT03833154
Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation treatment 3 active_not_recruiting NCT04603807
A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases treatment 3 recruiting NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without V940 in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009) treatment 3 not_yet_recruiting NCT06623487
The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT06623656
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC treatment 2 not_yet_recruiting NCT04931654
A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer treatment 1 / 2 recruiting NCT04956640
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) treatment 1 / 2 recruiting NCT05194072
A Study of SGN-B7H4V in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05241834
A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment No drug interventions treatment 1 active_not_recruiting NCT05298423
Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006/KEYVIBE-006) treatment 3 recruiting NCT05397171
A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours treatment 1 / 2 terminated NCT05642195
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer treatment 1 / 2 suspended NCT06627738
Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost No drug interventions treatment 2 not_yet_recruiting NCT06003231
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 treatment 2 recruiting NCT06012435
A Study of Sigvotatug Vedotin Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer (Be6A Lung-01). treatment 3 recruiting NCT06447662
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. treatment 1 recruiting NCT04538664
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions treatment 3 active_not_recruiting NCT04592523
A Study of Usage of Brigatinib in the Treatment of Adult Participants for Approved Indications In South Korea No drug interventions Not Available Not Available recruiting NCT04738487
Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003) treatment 3 recruiting NCT04988295
A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure treatment 3 active_not_recruiting NCT05208762
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors treatment 1 recruiting NCT05241873
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations treatment 1 / 2 active_not_recruiting NCT05358249
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation treatment 1 / 2 active_not_recruiting NCT05460273
A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02) treatment 1 / 2 active_not_recruiting NCT05488314
A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer treatment 1 / 2 active_not_recruiting NCT05498428
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer treatment 2 recruiting NCT05663866
Premedication to Reduce Amivantamab Associated Infusion Related Reactions treatment 2 active_not_recruiting NCT05826366
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI No drug interventions Not Available Not Available active_not_recruiting NCT05872763
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery No drug interventions Not Available Not Available recruiting NCT05908734
A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT05983133
A Study of SGN-EGFRd2 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06008093
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients treatment 3 recruiting NCT06116786
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer treatment 1 recruiting NCT06119581
A Study of LY3537982 Plus Immunotherapy With or Without Chemotherapy in Participants With Non-Small Cell Lung Cancer (NSCLC) With a Change in a Gene Called KRAS G12C treatment 3 recruiting NCT06120140
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib treatment 2 recruiting NCT06131840
A Study of PF-08046050 (SGN-CEACAM5C) in Adults With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06140836
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3) treatment 3 recruiting NCT06376084
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC No drug interventions Not Available Not Available recruiting NCT06400472
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06532032
A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT06549816
A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors treatment 1 recruiting NCT02208843
Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation treatment 4 completed NCT00153803
Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT00632203
Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) treatment 2 terminated NCT00890903
Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC) No drug interventions Not Available Not Available completed NCT00400803
Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer treatment 2 completed NCT01823003
Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases No drug interventions treatment 2 unknown_status NCT00097903
Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer treatment 1 completed NCT03125603
Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer No drug interventions Not Available Not Available completed NCT02134990
Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer treatment 2 unknown_status NCT03706690
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients treatment 3 active_not_recruiting NCT02695290
Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3) treatment 4 terminated NCT00049790
Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer treatment 2 completed NCT00136890
PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers No drug interventions diagnostic 3 completed NCT05498064
A Real World Study of Ensartinib in Advanced ALK-positive NSCLC Not Available Not Available recruiting NCT00184964
Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis No drug interventions diagnostic Not Available unknown_status NCT04529564
Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA) No drug interventions Not Available Not Available completed NCT00136864
Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial) No drug interventions diagnostic 3 completed NCT02151721
Phase I of Vorinostat-Iressa Combined Therapy on Resistance by BIM Polymorphysim in EGFR Mutant Lung Cancer treatment 1 unknown_status NCT00281021
Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer treatment 2 terminated NCT04665921
A Study of SGN-STNV in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT00193921
Chemoradiotherapy in Patients With Localised Lung Cancer treatment 2 completed NCT01877902
Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System No drug interventions Not Available Not Available unknown_status NCT02182102
Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer treatment 1 completed NCT03643484
IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy No drug interventions Not Available Not Available completed NCT00923884
Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer No drug interventions Not Available Not Available completed NCT02004184
Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy treatment 3 terminated NCT02083679
Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer treatment 1 terminated NCT04025879
A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer treatment 3 active_not_recruiting NCT04974879
Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer treatment 2 recruiting NCT06566443
Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer prevention 1 not_yet_recruiting NCT02366143
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT02758587
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) treatment 1 / 2 unknown_status NCT06466187
A Study of SGN-MesoC2 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01419587
Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG) No drug interventions treatment Not Available terminated NCT01523587
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy treatment 3 completed NCT01233687
AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00086333
FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma treatment 2 completed NCT03700333
Clinical Research of S-1 Versus Pemetrexed in the Maintenance Treatment of Advanced NSNSCLC treatment 3 unknown_status NCT04486833
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib treatment 1 / 2 recruiting NCT02211833
Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer treatment 1 completed NCT00561054
Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC treatment 2 unknown_status NCT02758054
Patient Navigation for Lung Cancer Screening in an Urban Safety-Net System No drug interventions screening Not Available completed NCT02531854
A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction Chemotherapy treatment 2 withdrawn NCT02904954
Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer treatment 2 completed NCT02440854
Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings Not Available Not Available completed NCT02811354
Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M Mutations Detected in Plasma Ct-DNA treatment 2 unknown_status NCT00098254
BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer treatment 2 completed NCT02956551
Personalized DC Vaccine for Lung Cancer No drug interventions treatment 1 unknown_status NCT01578551
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. treatment 2 terminated NCT00268151
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer treatment 1 terminated NCT00126451
A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) treatment 2 terminated NCT02894853
Lung Cancer Early Molecular Assessment Trial No drug interventions Not Available Not Available unknown_status NCT01814553
ADAM-Afatinib Diarrhea Assessment and Management treatment 3 completed NCT02342353
Pacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI) treatment 1 terminated NCT03586453
Osimertinib In EGFR Mutant Lung Cancer treatment 2 recruiting NCT03891953
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. treatment 1 active_not_recruiting NCT04452877
A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC treatment 2 active_not_recruiting NCT04823377
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer. No drug interventions supportive_care Not Available recruiting NCT03827577
OMEGA, Local Ablative Therapy in Oligometastatic NSCLC No drug interventions treatment 3 unknown_status NCT00266877
Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT04993677
A Study of SEA-CD40 Given With Other Drugs in Cancers treatment 2 active_not_recruiting NCT00243347
The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer treatment 1 completed NCT03261947
A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors treatment 2 completed NCT00036647
OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer treatment 3 completed NCT01545947
Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer treatment 1 completed NCT02224547
Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System No drug interventions treatment 2 unknown_status NCT00181545
Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients. No drug interventions treatment 1 completed NCT02711345
A Phase I Clinical Study With Investigational Compound LTT462 in Adult Patients With Specific Advanced Cancers. treatment 1 terminated NCT02671045
Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer No drug interventions Not Available Not Available terminated NCT00522145
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib treatment 2 completed NCT01860898
A Phase I Study of iPS Cell Generation From Patients With COPD No drug interventions basic_science Not Available completed NCT03337698
A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer) treatment 1 / 2 active_not_recruiting NCT00260598
LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer No drug interventions screening 2 terminated NCT00252798
ZD1839 (Iressa™) and Concurrent Chemo-Radiation in Patients With Locally Advanced Non Small Cell Lung Cancer treatment 1 completed NCT04165798
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01) No drug interventions Not Available Not Available recruiting NCT03871205
Neoantigen-primed DC Vaccines Therapy for Refractory Lung Cancer No drug interventions treatment 1 unknown_status NCT00915005
Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence treatment 2 completed NCT02879097
Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC treatment 3 unknown_status NCT02961283
Study of ASN003 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT00168883
Study for Patients With Non Small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT00365183
Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer treatment 2 terminated NCT04947683
Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil No drug interventions Not Available Not Available completed NCT04391283
First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting Not Available Not Available active_not_recruiting NCT02759783
Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases No drug interventions treatment 2 / 3 active_not_recruiting NCT06039683
A Multicountry, Multicentre, Non-interventional, Retrospective Study to Determine Real-world Treatment Patterns and Associated Outcomes After First Line Osimertinib in Patients With Advanced and Metastatic NSCLC EGFRm in the GCC Region No drug interventions Not Available Not Available completed NCT00906061
Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients treatment 2 unknown_status NCT02826161
A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer treatment 3 terminated NCT03408561
Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer No drug interventions health_services_research Not Available withdrawn NCT01799161
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer treatment 1 withdrawn NCT01069328
Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC) basic_science 1 completed NCT00819728
Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT04471428
Study of Atezolizumab in Combination With Cabozantinib Versus Docetaxel in Patients With Metastatic Non-Small Cell Lung Cancer Previously Treated With an Anti-PD-L1/PD-1 Antibody and Platinum-Containing Chemotherapy treatment 3 active_not_recruiting NCT00087711
A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer treatment 3 completed NCT01090011
Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer treatment 1 completed NCT00256711
Phase II Iressa Versus Vinorelbine (INVITE) treatment 2 completed NCT03983811
Adjuvant Chemotherapy With or Without Intercalated Icotinib treatment Not Available not_yet_recruiting NCT00661011
Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy No drug interventions treatment 2 terminated NCT02556593
IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases treatment 2 terminated NCT00198393
Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV treatment 2 completed NCT00932893
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene treatment 3 completed NCT00835471
2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT04731571
Toward High Fidelity Adaptive Radiotherapy in the Thorax No drug interventions Not Available Not Available not_yet_recruiting NCT00210171
Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer No drug interventions treatment 2 terminated NCT03380871
A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer treatment 1 completed NCT03909971
A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China treatment 2 active_not_recruiting NCT02273271
Evaluation of FLT-PET and DWI-MRI in Patients With NSCLC Treated With a Platinum-based Doublet as Preoperative Chemo No drug interventions basic_science Not Available unknown_status NCT00954278
Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer treatment 1 completed NCT00284778
Pharmaco-economic Study of a Second Line Treatment in Advanced Non Small Cell Lung Cancer treatment 3 completed NCT00826878
An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT03172988
Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery supportive_care 4 terminated NCT03331588
Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer No drug interventions treatment 3 completed NCT04543188
A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain Involvement treatment 1 terminated NCT00071188
ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00328588
LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy treatment 2 completed NCT00775307
Adjuvant Pazopanib in Stage I NSCLC treatment 2 / 3 completed NCT00592007
Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer treatment 2 terminated NCT03155009
A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer treatment 2 completed NCT03485209
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors treatment 2 recruiting NCT04676009
Feasibility of an Acute Physical Exercise Before Treatment Infusion for Metastatic Lung Cancer Patients No drug interventions supportive_care Not Available completed NCT00977509
Gene Mutations in Non-Small Cell Lung Cancer Cells No drug interventions Not Available Not Available unknown_status NCT00088556
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00076856
Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) treatment 2 completed NCT03432156
Autologous Tcm Cells Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 2 unknown_status NCT02795156
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations treatment 2 completed NCT00191256
Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer treatment 2 completed NCT00178256
Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer treatment 1 / 2 completed NCT02751385
Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer other 1 terminated NCT00720785
Natural Killer Cells and Bortezomib to Treat Cancer treatment 1 completed NCT00300885
A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) treatment 3 terminated NCT01478685
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors treatment 1 completed NCT02813785
A Study of Atezolizumab Compared With Docetaxel in Non-Small Cell Lung Cancer (NSCLC) After Failure With Platinum-Containing Chemotherapy treatment 3 completed NCT05435885
Effects of Comprehensive Postoperative Pulmonary Tele-Rehabilitation in Elderly Patients With Resectable Lung Cancer No drug interventions treatment Not Available completed NCT05599685
A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT00066885
Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT03840915
M7824 in Combination With Chemotherapy in Stage IV Non-small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT00256815
Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study No drug interventions treatment 1 / 2 completed NCT06075615
A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain. No drug interventions Not Available Not Available not_yet_recruiting NCT00444015
Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC) treatment 1 completed NCT00535015
Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer No drug interventions treatment 2 terminated NCT01494415
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer treatment 2 unknown_status NCT00753415
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) No drug interventions treatment 1 completed NCT00081315
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer prevention 2 completed NCT00238615
Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC treatment 2 terminated NCT00321815
Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer treatment 2 completed NCT06475937
A Study of DM001 in Patients With Advanced Solid Tumors treatment 1 not_yet_recruiting NCT04224337
Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma treatment 2 active_not_recruiting NCT03050437
A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI treatment 2 unknown_status NCT04397432
Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC：Retrospective Study No drug interventions Not Available Not Available active_not_recruiting NCT00181532
Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC treatment 2 completed NCT00093132
Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy treatment 1 / 2 terminated NCT02182232
A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer treatment 1 completed NCT00310232
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20) treatment 3 terminated NCT00625352
Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma treatment 2 unknown_status NCT02193152
Pazopanib in Molecularly Selected Patients With Advanced NSCLC treatment 2 terminated NCT01909752
Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer treatment 2 completed NCT03603652
NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung No drug interventions treatment Not Available terminated NCT02343952
Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC treatment 2 completed NCT03200600
Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery prevention 4 terminated NCT01946100
Treatment of Multifocal Lung Adenocarcinoma No drug interventions treatment Not Available active_not_recruiting NCT05229900
A Study of SGN-ALPV in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT01374100
Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy No drug interventions supportive_care Not Available terminated NCT05225259
Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET Inhibitor No drug interventions Not Available Not Available no_longer_available NCT01985659
Nodal Upstaging in VATS Anatomical Resections for NSCLC No drug interventions Not Available Not Available unknown_status NCT02131259
Long-term Observation PMS for Afatinib Not Available Not Available completed NCT04170959
The Addition of Metformin to Definitive Radiotherapy in Patients With Stage III NSCLC treatment 2 terminated NCT04762459
Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection treatment 3 enrolling_by_invitation NCT02491775
Afatinib Genomic Landscape No drug interventions Not Available Not Available terminated NCT03236675
Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients No drug interventions Not Available Not Available unknown_status NCT03971175
Influence of Biopsy Technique on Moleculargenetic Tumor Characterisation in NSCLC No drug interventions diagnostic Not Available unknown_status NCT00312975
Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT03995875
Real World Evidence of Long-term Safety and Efficacy in Patients Treated With Durvalumab After Concurrent Chemoradiation for Unresectable Stage III NSCLC No drug interventions Not Available Not Available completed NCT04853342
To Assess the Efficacy and Safety of Furmonertinib Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage II-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy No drug interventions treatment 3 not_yet_recruiting NCT02166242
Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers treatment 1 completed NCT00153842
A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer treatment 1 / 2 terminated NCT04465942
Immunotherapy in Lung Cancer: Treatment After IO Cessation. Not Available Not Available recruiting NCT03102242
Atezolizumab Immunotherapy in Patients With Advanced NSCLC treatment 2 completed NCT02567799
BIO 300 Non-Small Cell Lung Cancer Study prevention 1 / 2 completed NCT00001499
Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer treatment 2 completed NCT03770299
An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease treatment 2 withdrawn NCT00054899
An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer No drug interventions treatment 1 completed NCT03713099
NEUWAVE Flexible Probe Study #2 No drug interventions treatment Not Available withdrawn NCT03784599
T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC treatment 2 terminated NCT02376699
Safety Study of SEA-CD40 in Cancer Patients treatment 1 terminated NCT00232206
Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer treatment 2 terminated NCT01931306
Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC) Not Available Not Available approved_for_marketing NCT00568906
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma No drug interventions Not Available Not Available terminated NCT02009449
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors treatment 1 active_not_recruiting NCT00796549
BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients treatment 2 completed NCT04879849
A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers treatment 1 completed NCT00673049
Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer treatment 3 terminated NCT04255836
Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC) treatment 2 unknown_status NCT03672136
Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients treatment 2 unknown_status NCT04380636
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) treatment 3 active_not_recruiting NCT00656136
BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1) treatment 3 completed NCT00558636
A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) treatment 3 terminated NCT00791336
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer treatment 2 terminated NCT05603013
Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0) treatment 2 not_yet_recruiting NCT00101413
BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC) treatment 2 completed NCT02655913
Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer treatment 1 / 2 completed NCT06481813
Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients No drug interventions basic_science Not Available not_yet_recruiting NCT01444118
A Randomized Trial to Study the Safety and Efficacy of EGF Cancer Vaccination in Late-stage (IIIB/IV) Non-small Cell Lung Cancer Patients Not Available 3 terminated NCT00162318
A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer treatment 1 completed NCT02645318
Comparison of Circulating Tumor DNA and Tumor Tissue DNA by Targeted Sequencing in Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT00145418
Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer treatment 2 terminated NCT03023319
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors treatment 1 completed NCT03053219
Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment treatment 1 completed NCT01004419
Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer treatment 1 withdrawn NCT04527419
SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009) No drug interventions treatment Not Available recruiting NCT00034541
Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00191841
Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy treatment 2 completed NCT00568841
Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) diagnostic 2 unknown_status NCT03083041
A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC) treatment 2 completed NCT00379717
Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 unknown_status NCT01648517
Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy treatment 2 completed NCT00290017
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy treatment 3 terminated NCT04023617
A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC treatment 2 unknown_status NCT05302817
Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI diagnostic 1 recruiting NCT04351334
Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns Not Available Not Available completed NCT00171834
Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer treatment 1 / 2 completed NCT01915524
Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 terminated NCT05068024
A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 recruiting NCT03233724
Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas treatment 1 / 2 terminated NCT02400424
Study of the Efficacy of SBRT on Unresectable Peripheral Primary Tumor No drug interventions treatment Not Available terminated NCT01109524
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer treatment 2 completed NCT00404924
ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures treatment 3 completed NCT00035516
A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy No drug interventions treatment 2 completed NCT00207116
An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma treatment 1 completed NCT01941316
Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients treatment 1 / 2 completed NCT04075396
A Study of Lazertinib in Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 completed NCT04165096
KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C) treatment 2 active_not_recruiting NCT00796796
Temsirolimus and Radiation for Non-Small Cell Lung Cancer treatment 1 completed NCT00385996
Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer treatment 2 completed NCT02710396
Genetic Predictors of Benefit to Pembrolizumab treatment 2 terminated NCT00157196
Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease treatment 2 completed NCT02777658
PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC No drug interventions Not Available Not Available completed NCT03802058
Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer treatment 2 terminated NCT02737735
The Effect on Decreasing Chemotherapeutic Toxicity and Increasing Anti-tumor Effect of Chinese Herbs Based on Syndrome Differentiation No drug interventions treatment 1 unknown_status NCT02714335
The Correlation Between MAGE-A3, PRAME Polymorphism and Expression Levels of MAGE-A3 and PRAME in NSCLC Patients No drug interventions Not Available Not Available completed NCT04077463
A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer treatment 1 recruiting NCT03285763
A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) treatment 4 completed NCT04151563
A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy treatment 1 / 2 withdrawn NCT02432963
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy treatment 1 active_not_recruiting NCT00108186
Celecoxib Treatment for Lung Cancer basic_science 1 withdrawn NCT05401786
Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC treatment 2 recruiting NCT02414139
Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1) treatment 2 completed NCT02416739
Anticancer Activity of Nicotinamide on Lung Cancer treatment 2 / 3 unknown_status NCT06115239
QOL After SURGERY and ADJUVANT Treatment No drug interventions Not Available Not Available not_yet_recruiting NCT01786122
Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients No drug interventions supportive_care Not Available unknown_status NCT01385722
Molecular Analysis of Thoracic Malignancies No drug interventions Not Available Not Available enrolling_by_invitation NCT03745222
A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer treatment 3 terminated NCT02671422
LUME BioNIS: a Biomarker Study in Patients With NSCLC No drug interventions Not Available Not Available completed NCT00132522
EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide No drug interventions treatment 1 completed NCT00425022
VATS Lobectomy for Clinical Stage IB or II Lung Cancer No drug interventions treatment 2 unknown_status NCT04825925
Drug-eluting Beads Bronchial Arterial Chemoembolization in Stage II-III Non-small-cell Lung Cancer Patients Failed, Refused or Ineligible to Receive Standard Treatments No drug interventions treatment Not Available not_yet_recruiting NCT04426825
A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer treatment 2 completed NCT05037825
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors No drug interventions Not Available Not Available recruiting NCT00201825
A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients treatment 2 completed NCT00191230
Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer treatment 2 completed NCT02805530
Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma No drug interventions treatment Not Available completed NCT00215930
The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT01192230
Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients treatment 2 unknown_status NCT05865730
A Study of Oncobax®-AK in Patients With Advanced Solid Tumors No drug interventions treatment 2 recruiting NCT00596830
Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology treatment 3 terminated NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) No drug interventions Not Available Not Available recruiting NCT02629848
Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer treatment 3 terminated NCT01034748
A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers basic_science 1 completed NCT01383148
Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer treatment 2 / 3 terminated NCT02394548
Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer No drug interventions treatment Not Available completed NCT01039948
A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00596648
A Study of XL184 (Cabozantinib) With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT04985357
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs No drug interventions Not Available Not Available not_yet_recruiting NCT04535557
An Expanded Access Protocol for Mobocertinib in Refractory Non-small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Exon20 Insertion Mutations Not Available Not Available approved_for_marketing NCT03268057
VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer treatment 1 / 2 completed NCT04167657
SinTilimab After Radiation (STAR Study) treatment 2 unknown_status NCT03141957
Hypermetabolism in the Elderly Lung Cancer Patient No drug interventions Not Available Not Available completed NCT00034957
Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) No drug interventions treatment 2 completed NCT02250326
Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer treatment 2 completed NCT03740126
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy No drug interventions diagnostic Not Available active_not_recruiting NCT03044626
Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC treatment 2 completed NCT00089726
A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT01853826
An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s) treatment 3 completed NCT01006226
64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab No drug interventions treatment Not Available withdrawn NCT03444766
Study of Nivolumab for Advanced Cancers in India treatment 4 completed NCT00864266
Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer No drug interventions diagnostic Not Available completed NCT03663166
Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 terminated NCT04148066
ctDNA Guided Treatment of Early Resistance to Targeted Treatment No drug interventions treatment Not Available completed NCT05393466
BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) No drug interventions treatment 1 / 2 not_yet_recruiting NCT03958565
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations. Not Available Not Available recruiting NCT00379665
Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy treatment 2 completed NCT00132665
Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301) treatment 3 completed NCT02514174
Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older treatment 4 completed NCT01487174
KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy treatment 3 terminated NCT02430974
Chemotherapy of NSCLC With or Without Icotinib treatment 2 unknown_status NCT01209520
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy treatment Not Available completed NCT02818920
Neoadjuvant Pembrolizumab treatment 2 active_not_recruiting NCT00654420
A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007) treatment 2 completed NCT01088620
Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer treatment 2 suspended NCT00270582
A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung Cancer treatment 2 unknown_status NCT00252382
Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC treatment 2 completed NCT06270082
Study of IK-595 in RAS- or RAF-altered Advanced Tumors No drug interventions treatment 1 recruiting NCT03166631
A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread treatment 1 terminated NCT00539331
Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients treatment 1 terminated NCT01956331
Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer No drug interventions Not Available Not Available completed NCT00923273
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT05573373
Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer treatment 1 recruiting NCT00565227
Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. treatment 1 terminated NCT02562027
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer No drug interventions health_services_research Not Available completed NCT00973427
DNA Chip Based Prognosis of Lung Cancer No drug interventions Not Available Not Available completed NCT03148327
Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy treatment 1 / 2 active_not_recruiting NCT03270176
A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy treatment 1 completed NCT00511576
Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors treatment 1 terminated NCT03456076
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT00564876
Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer treatment 2 terminated NCT06186076
A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients No drug interventions treatment 1 / 2 recruiting NCT01027676
Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC) No drug interventions treatment 1 / 2 unknown_status NCT00979576
BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC) treatment 1 terminated NCT03658460
Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers No drug interventions Not Available Not Available completed NCT00040560
Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer No drug interventions diagnostic 1 unknown_status NCT00112060
A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 withdrawn NCT03479294
Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection Not Available Not Available terminated NCT03546894
A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors Not Available Not Available completed NCT00711594
LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib treatment 2 completed NCT00094094
Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT03580694
Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 1 terminated NCT06484491
IMPT Dose Escalation for NSCLC (HyDose) treatment Not Available not_yet_recruiting NCT02411591
A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT02954991
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer treatment 2 terminated NCT00254891
Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer treatment 3 terminated NCT02191891
Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) treatment 1 completed NCT06282991
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled Not Available Not Available completed NCT02905591
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC treatment 2 recruiting NCT05487391
A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection. treatment 3 not_yet_recruiting NCT06221462
Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT02519062
Role of FDG PET, Immune and Hypoxic Marker in NSCLC No drug interventions Not Available Not Available completed NCT00294762
Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC treatment 2 completed NCT02919462
Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and Oral Vinorelbine in Chemotherapy Naïve Patients Affected by Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer With High Thymidylate Synthase Expression treatment 2 terminated NCT02628080
Atovaquone as Tumour HypOxia Modifier treatment 0 completed NCT04862780
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC treatment 1 / 2 active_not_recruiting NCT00540280
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer No drug interventions treatment 3 suspended NCT04487080
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 active_not_recruiting NCT01260480
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation No drug interventions diagnostic 2 unknown_status NCT04579380
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations treatment 2 active_not_recruiting NCT01897480
A Study of LY2875358 in Participants With Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations treatment 2 active_not_recruiting NCT04000529
Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies treatment 1 terminated NCT03455829
G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT01131429
A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations treatment 2 unknown_status NCT00070629
CPG 7909 Injection in Non-Small Cell Lung Cancer treatment 2 completed NCT05715229
Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy treatment 2 recruiting NCT03157089
Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung treatment 2 completed NCT02952989
A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors treatment 1 terminated NCT05737589
Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis No drug interventions Not Available Not Available not_yet_recruiting NCT01602289
A Study of LY2875358 in Japanese Participants With Advanced Cancer treatment 1 completed NCT00466089
Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer treatment 2 unknown_status NCT04741789
Treatment Plan CINC280A02001M to Provide Access to Capmatinib, for MET Exon 14 Skipping Non-Small Cell Lung Cancer (NSCLC) Not Available Not Available available NCT06222489
Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT No drug interventions diagnostic 2 not_yet_recruiting NCT03721289
Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer Patients No drug interventions Not Available Not Available completed NCT00251589
A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025) treatment 1 / 2 terminated NCT04878692
Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies No drug interventions prevention Not Available unknown_status NCT02607592
A Prospective Multi-center Phase III Randomized Controlled Trial treatment 3 unknown_status NCT02664792
Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer No drug interventions diagnostic Not Available completed NCT01610544
18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma No drug interventions diagnostic 2 withdrawn NCT05208944
THIO Sequenced With Cemiplimab in Advanced NSCLC treatment 2 recruiting NCT00432640
Assessment of Surgical sTaging vs Endoscopic Ultrasound in Lung Cancer: a Randomized Clinical Trial (ASTER Study) No drug interventions diagnostic Not Available completed NCT00190840
A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT03088540
Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT02875340
A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT02187367
Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients treatment 3 terminated NCT02592967
Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer treatment 1 terminated NCT00531401
Study of Salirasib to Treat Non-Small Cell Lung Cancer diagnostic 2 completed NCT00167401
Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer treatment 2 completed NCT00092001
Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT00047801
Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00243204
Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy treatment 3 terminated NCT01740804
Dynamic Circulating Tumor Cell (CTC) Changes During the Chemotherapy in NSCLC No drug interventions Not Available Not Available completed NCT00254904
Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC treatment 3 terminated NCT05167604
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC No drug interventions Not Available Not Available recruiting NCT03918304
Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy - PLUS No drug interventions Not Available Not Available recruiting NCT00907504
Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer treatment 3 withdrawn NCT00222404
Pharmacogenomic Study Realized on "Non-small Cell Lung Carcinoma" No drug interventions Not Available Not Available completed NCT04222972
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT04427072
Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation treatment 3 completed NCT03134872
A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC treatment 3 completed NCT00125372
Study of Tarceva and Targretin in Stage I-II Lung Cancer treatment Not Available completed NCT00329472
Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer treatment 3 withdrawn NCT00313768
Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLC treatment 2 terminated NCT02926768
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors treatment 1 completed NCT00043368
PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) treatment 2 completed NCT00034268
A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer treatment 3 completed NCT00234468
Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC treatment 3 terminated NCT00608868
SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients treatment 4 completed NCT05609968
Study of Pembrolizumab (MK-3475) Monotherapy Versus Sacituzumab Govitecan in Combination With Pembrolizumab for Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-3475-D46) treatment 3 recruiting NCT04385368
Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC) treatment 3 completed NCT02966769
N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation No drug interventions Not Available Not Available completed NCT00160069
Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer treatment 2 completed NCT02431169
Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression No drug interventions Not Available Not Available terminated NCT04884269
A Non Interventional Pilot Study on Machine Learning for ILD Detection Based on the Patient Data From Digital Devices in Unresectable Stage III Non-Small Cell Lung Cancer Patients Receiving Durvalumab No drug interventions Not Available Not Available completed NCT04642469
Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy. treatment 3 completed NCT00174369
MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT01319669
Clinical Trial on the Prevention of Thrombocytopenia After First-line Chemotherapy treatment 2 / 3 terminated NCT00252746
ZD6474 Phase IIa Dose Finding Multicentre Study treatment 2 completed NCT00112346
Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer treatment 2 completed NCT02597946
Afatinib in NSCLC With HER2 Mutation treatment 2 completed NCT04697446
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC No drug interventions Not Available Not Available unknown_status NCT02088112
MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC). treatment 1 completed NCT02623712
The Watch the Spot Trial No drug interventions diagnostic Not Available active_not_recruiting NCT00266812
Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED) treatment 2 terminated NCT00842712
Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00732810
SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716) treatment 2 completed NCT00921310
Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT00973310
Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer No drug interventions treatment 2 unknown_status NCT03345810
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) treatment 2 completed NCT04794010
A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT02422381
MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) treatment 1 / 2 active_not_recruiting NCT05104281
Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer treatment 3 recruiting NCT03735095
Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer treatment 1 / 2 active_not_recruiting NCT02623595
A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy treatment 2 withdrawn NCT02487095
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers treatment 1 / 2 active_not_recruiting NCT02420314
Pharmacological Ascorbate for Lung Cancer treatment 2 completed NCT03975114
A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5) treatment 2 recruiting NCT02844114
Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy treatment 2 unknown_status NCT05529355
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer treatment 2 unknown_status NCT02392455
VARGADO - Vargatef in 2nd-line Therapy of Non-Small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available active_not_recruiting NCT00386555
A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel. treatment 2 withdrawn NCT00768755
Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT04291755
Development and Analysis of a Stool Bank for Cancer Patients Not Available Not Available recruiting NCT00985855
Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer treatment 2 completed NCT00949650
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation treatment 3 completed NCT00497250
Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy treatment 1 unknown_status NCT02689050
Optical Biopsy for Thoracic Lymph Nodes. No drug interventions Not Available Not Available completed NCT03678350
Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery treatment 1 active_not_recruiting NCT00727350
Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma. No drug interventions treatment 2 unknown_status NCT00423150
Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) treatment 2 terminated NCT00994123
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT03669523
Denosumab and Nivolumab Combination as 2d-line Therapy in Stage IV NSC Lung Cancer With Bone Metastases (DENIVOS) treatment 2 active_not_recruiting NCT03181308
Study of Carotuximab (TRC105) Plus Nivolumab in Patients With Metastatic NSCLC treatment 1 completed NCT00824408
Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC treatment 2 completed NCT02381808
Study on Potential Biomarkers Associated With Clinical Phenotype of EGFR-TKIs in No-small Cell Lung Cancer in China No drug interventions Not Available Not Available unknown_status NCT04294108
Why in Hospital After VATS Lobectomy No drug interventions Not Available Not Available completed NCT01279408
Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC) No drug interventions Not Available Not Available active_not_recruiting NCT03052608
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC treatment 3 active_not_recruiting NCT00522938
Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer supportive_care 1 / 2 terminated NCT05698238
Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours No drug interventions treatment 1 not_yet_recruiting NCT00040638
Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT00044538
Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients treatment 2 completed NCT02142738
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024) treatment 3 completed NCT02047903
GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations Not Available Not Available completed NCT01115803
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors treatment 1 terminated NCT04194203
A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151) treatment 3 completed NCT02448303
Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT02489903
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) treatment 2 completed NCT03786003
ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007) No drug interventions treatment Not Available recruiting NCT02370303
A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System No drug interventions Not Available Not Available completed NCT02590003
Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer treatment 2 terminated NCT02410603
Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer No drug interventions Not Available Not Available completed NCT01115790
A Phase 1 Study in Participants With Advanced Cancer treatment 1 completed NCT06515990
A Study of DM005 in Patients With Advanced Solid Tumors No drug interventions treatment 1 not_yet_recruiting NCT00352690
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer treatment 2 terminated NCT00191490
A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer treatment 2 completed NCT00034164
Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer treatment 2 completed NCT02231164
LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research treatment 3 terminated NCT02647164
The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring No drug interventions Not Available Not Available unknown_status NCT00061464
Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy. treatment 2 completed NCT01514864
Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation treatment 2 terminated NCT00600821
A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. treatment 2 completed NCT01802021
Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients No drug interventions supportive_care 2 / 3 unknown_status NCT02937402
Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung Cancer No drug interventions diagnostic Not Available terminated NCT03574402
Phase II Umbrella Study Directed by Next Generation Sequencing treatment 2 recruiting NCT00087802
Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT00406302
Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC) treatment 2 completed NCT00349102
Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer No drug interventions treatment 3 completed NCT03170284
Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung Cancer Not Available Not Available completed NCT01153984
A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations treatment 2 completed NCT03529084
Phase III Study of Nazartinib (EGF816) Versus Erlotinib/Gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations treatment 3 withdrawn NCT01649284
Afatinib Expanded Access Program Not Available Not Available approved_for_marketing NCT04926584
Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option No drug interventions Not Available Not Available recruiting NCT00268684
Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC Not Available 3 unknown_status NCT00132379
ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer treatment 1 completed NCT04515979
Vactosertib in Combination With Pembrolizumab for PD-L1 Positive Non-small Cell Lung Cancer (NSCLC) Subjects treatment 2 recruiting NCT03262779
Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer. treatment 2 completed NCT02751879
Real World Data on Gi(l)Otrif® Dose Adjustment No drug interventions Not Available Not Available completed NCT04990479
Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma No drug interventions treatment 1 active_not_recruiting NCT00042679
A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. treatment 2 completed NCT00600587
Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00449033
A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT06431633
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free. treatment 2 not_yet_recruiting NCT03590054
Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies treatment 1 completed NCT04951154
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer No drug interventions Not Available Not Available completed NCT00553254
Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer treatment 2 completed NCT02098954
Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers treatment 2 recruiting NCT02049151
Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer treatment 3 terminated NCT00117351
VELCADE in Previously Treated Patients With Stage IIIB and IV Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma With BAC Features treatment 2 terminated NCT01413451
Amatuximab for High Mesothelin Cancers treatment 0 terminated NCT06001151
Cadonilimab (AK104) Plus Chemotherapy as First-line Treatment in Non-squamous Non-Small Cell Lung Cancer (NSCLC) Patients With Programmed Cell Death Ligand 1 (PD-L1) Negative treatment 2 recruiting NCT02864251
A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy treatment 3 completed NCT00932451
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene treatment 2 completed NCT00061451
Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial treatment 2 completed NCT00535951
Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma treatment 1 completed NCT00097851
Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC) treatment 2 completed NCT01282151
TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer treatment 3 terminated NCT02718651
Blood-based Identification and Monitoring of Patients With ALK-translocated Lung Cancer No drug interventions Not Available Not Available completed NCT00424853
ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC) treatment 2 completed NCT04499053
Durvalumab and Tremelimumab in Combination With Chemotherapy in Virus-infected Patients With Non-small Cell Lung Cancer treatment 2 recruiting NCT01421953
Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers No drug interventions supportive_care Not Available completed NCT02762877
Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer No drug interventions Not Available Not Available terminated NCT02922777
Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer. treatment 1 completed NCT02847377
A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC No drug interventions diagnostic Not Available completed NCT05263947
Bevacizumab Combined With Double Dose Icotinib in Patients With EGFR Exon 21-L858R Mutation treatment 2 recruiting NCT04776447
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) treatment 2 active_not_recruiting NCT02916147
Effect of Different Anesthetics on the Change of Alarmins in Lung Cancer Patients Receiving Pulmonary Lobectomy basic_science Not Available unknown_status NCT05306847
Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer treatment 2 not_yet_recruiting NCT02186847
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT02834247
A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors other 1 terminated NCT01048645
Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT00831545
Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064) treatment 2 completed NCT00585845
Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment treatment 1 terminated NCT03396445
Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001) treatment 1 active_not_recruiting NCT06560645
A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation No drug interventions treatment 1 not_yet_recruiting NCT00251498
Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT03752398
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) treatment 1 completed NCT02300298
Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy treatment 1 completed NCT00213798
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients No drug interventions screening Not Available completed NCT05885698
MYLUNG Consortium Part 3: Observational Study No drug interventions Not Available Not Available recruiting NCT02574598
MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients treatment 2 completed NCT00264498
Phase II Iressa & Carbo/Gem in NSCLC treatment 2 completed NCT03715205
Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593) treatment 4 completed NCT00102505
A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC) treatment 1 completed NCT03053297
Observational Study of Patients With Locally Advanced or Metastatic NSCLC (Non-Small Cell Lung Cancer) No drug interventions Not Available Not Available terminated NCT00034697
Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143) treatment 2 terminated NCT00905983
Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients treatment 2 unknown_status NCT04165083
KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B) treatment 2 active_not_recruiting NCT01449461
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigatinib (AP26113) treatment 1 / 2 completed NCT02285361
GIOTRIF rPMS in Korean Patients With NSCLC Not Available Not Available completed NCT02537561
Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors treatment 1 withdrawn NCT01441128
-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer treatment 1 terminated NCT01647711
A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations treatment 1 completed NCT04984811
NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC treatment 2 active_not_recruiting NCT02135211
Healthy Directions After Lung Surgery Pilot No drug interventions treatment Not Available completed NCT06269211
Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer With EGFR Mutation and PD-L1 Positive Expression treatment 2 not_yet_recruiting NCT01415011
Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients treatment 2 completed NCT00139711
Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer treatment 2 completed NCT01684111
An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Vinorelbine in Elderly Patients With Advanced Non Small Lung Cell Cancer - Stage IV (VENUS-1) treatment 1 completed NCT01801111
A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment treatment 1 / 2 completed NCT04948411
Durvalumab as Maintenance in Patients Who Received Chemoradiotherapy for Unresectable Stage III NSCLC: Real World Data From an Expanded Access Program in Brazil No drug interventions Not Available Not Available completed NCT00622193
Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer treatment 2 completed NCT01121393
BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC) treatment 3 completed NCT02668393
Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma treatment 1 completed NCT03232593
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) Not Available Not Available completed NCT00548093
PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib treatment 2 completed NCT00051493
ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. treatment 2 completed NCT04597671
Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28) prevention 3 recruiting NCT05380271
Efficacy and Safety of DEB-BACE With Sequential Arotinib and Tirelizumab in the Treatment of Advanced NSCLC No drug interventions treatment 2 not_yet_recruiting NCT01022671
Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy treatment 2 completed NCT00051571
Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma treatment 2 completed NCT03258671
IMRT and Timing in Combination With EGFRTKI for Stage IV Non-small-cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT05768178
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. treatment 2 / 3 recruiting NCT00250978
Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC treatment 1 completed NCT03460678
Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients. treatment 4 terminated NCT00326378
Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer treatment 3 completed NCT02897778
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors treatment 1 completed NCT00094978
Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum treatment 1 terminated NCT05469178
A Study to Investigate the Safety, Tolerability, and Preliminary Anti-tumor Activity of Bemcentinib in Combination With Pembrolizumab Plus Pemetrexed and Carboplatin in Adult Participants With Untreated Non-squamous Non-small Cell Lung Cancer treatment 1 / 2 recruiting NCT03647488
Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung Cancer treatment 2 completed NCT02511288
LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT04699188
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation treatment 1 / 2 recruiting NCT03517488
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors treatment 1 completed NCT06068088
Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET) No drug interventions Not Available Not Available not_yet_recruiting NCT00076388
Iressa Versus Docetaxel (Taxotere) treatment 3 completed NCT00983307
A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer treatment 2 completed NCT02387307
A Study of rSIFN-co in Subjects With Advanced Solid Tumors treatment 1 completed NCT02960607
High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC treatment 2 unknown_status NCT00536107
Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) treatment 4 terminated NCT03001609
Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC treatment 1 completed NCT00157209
Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer) treatment 2 completed NCT02450656
Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer treatment 1 / 2 unknown_status NCT00100256
Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy treatment 1 / 2 recruiting NCT00174356
PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients treatment 1 completed NCT02289456
Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for First Line Treatment of NSCLC Subjects With ECOG PS 2 treatment 2 completed NCT05456256
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma treatment 2 recruiting NCT00098085
Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer Not Available 2 completed NCT00315185
Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer treatment 2 completed NCT01261585
Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT No drug interventions Not Available Not Available completed NCT03731585
Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment No drug interventions supportive_care Not Available active_not_recruiting NCT00073385
Comparative Trial of Pivanex and Docetaxel Vs Docetaxel Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT00775385
TAilored Post-Surgical Therapy in Early Stage NSCLC No drug interventions treatment 2 / 3 completed NCT03037385
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors treatment 1 / 2 completed NCT04585815
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study) treatment 1 / 2 active_not_recruiting NCT03439215
PF-06463922 for Crizotinib Pretreated ROS1 Positive Non-small-cell Lung Cancer treatment 2 unknown_status NCT05577715
A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Adenocarcinoma (AC) treatment 2 recruiting NCT05892237
CIETAI and Sequential Radiotherapy in Squamous Lung Cancer No drug interventions treatment 2 recruiting NCT05003037
Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer treatment 2 recruiting NCT00147537
Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer treatment 1 / 2 completed NCT00441337
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies treatment 1 completed NCT00056537
ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer treatment 1 completed NCT00100932
Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy treatment 2 completed NCT02062632
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy supportive_care 2 terminated NCT00420732
Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer No drug interventions treatment 2 terminated NCT05940532
A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC treatment 2 recruiting NCT01671332
Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT05934032
National Network Genomic Medicine Lung Cancer, Germany No drug interventions Not Available Not Available recruiting NCT04389632
A Study of SGN-B6A in Advanced Solid Tumors treatment 1 recruiting NCT01232452
A Study in Non-Small Cell Lung Cancer treatment 2 completed NCT05032352
Predictive Assay for Decision Making in Adjuvant Therapy No drug interventions Not Available Not Available terminated NCT02909452
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors treatment 1 completed NCT01900652
A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants treatment 2 completed NCT00035152
Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer treatment 3 completed NCT04461652
The Effect of a Combined Drainage Strategy in Uniportal Upper Lung Lobectomy No drug interventions prevention Not Available unknown_status NCT01469000
A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT00553800
Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer treatment 2 completed NCT04819100
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) treatment 3 recruiting NCT02804100
Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients No drug interventions Not Available Not Available unknown_status NCT00137800
Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients treatment 2 completed NCT00265200
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer diagnostic 2 terminated NCT01047059
Molecular Imaging With Erlotinib and Bevacizumab treatment 2 completed NCT03078959
Prognostic Value of PD-L1 in NSCLC No drug interventions Not Available Not Available unknown_status NCT02733159
Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2 treatment 2 active_not_recruiting NCT00125359
Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer treatment 2 completed NCT02204059
Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer treatment 1 completed NCT00069875
A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer treatment 2 completed NCT01836575
Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2 treatment 3 completed NCT00090675
Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 withdrawn NCT00535275
NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy No drug interventions treatment 3 terminated NCT06079970
Confocal Laser Endomicroscopy VERification No drug interventions diagnostic Not Available recruiting NCT02419170
Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC) treatment 0 withdrawn NCT03370770
Afatinib Osimertinib Sequencing NIS Not Available Not Available completed NCT04165070
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A) treatment 2 active_not_recruiting NCT00729742
Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008) treatment 1 completed NCT04432142
Immune Profiling of Stage III Non-small Cell Lung Cancer Patients Treated With Concurrent Chemoradiation and Adjuvant Durvalumab: A Prospective Observational Phase II Trial No drug interventions Not Available Not Available recruiting NCT03154242
Effect of Genetic Polymorphisms on Platinum Based Chemotherapy in Non Small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT01003899
A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR] treatment 2 completed NCT01261299
Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer treatment 0 terminated NCT05708599
A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer No drug interventions basic_science Not Available recruiting NCT00128999
Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer No drug interventions treatment 1 / 2 completed NCT00993499
Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib treatment 1 completed NCT05260606
Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT00034606
Comparing 3 Schedules of Alimta Plus Gemzar treatment 2 completed NCT01088906
Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC treatment 2 terminated NCT00181506
HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy No drug interventions treatment 1 / 2 completed NCT02775006
Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell Carcinoma treatment 3 terminated NCT05099549
Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers No drug interventions treatment 1 / 2 terminated NCT05163249
Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLC treatment 2 active_not_recruiting NCT00622349
Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer treatment 3 completed NCT00050336
Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED) treatment 3 terminated NCT05421936
Osimertinib for NSCLC With Uncommon EGFR Mutations Not Available Not Available suspended NCT02079636
A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC) treatment 1 completed NCT01085136
LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib treatment 3 completed NCT02655536
Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II Trial treatment 2 unknown_status NCT04323436
Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations treatment 2 terminated NCT02272413
Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer treatment 3 completed NCT01953913
Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation treatment 3 completed NCT00415818
Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer treatment 2 / 3 completed NCT00115518
Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02146118
A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma treatment 2 unknown_status NCT00806819
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC treatment 3 completed NCT04748419
Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab treatment 1 / 2 recruiting NCT04887519
A Study of Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT00063219
Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy treatment 2 completed NCT00198341
Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up No drug interventions treatment Not Available completed NCT00256841
Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy No drug interventions treatment 1 / 2 withdrawn NCT02299141
Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer treatment 2 active_not_recruiting NCT06494241
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study No drug interventions Not Available Not Available not_yet_recruiting NCT01497041
A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment treatment 2 unknown_status NCT03446417
A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer No drug interventions treatment 1 completed NCT01592617
Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer No drug interventions treatment 2 unknown_status NCT00265317
A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone treatment 2 completed NCT05250817
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT00037817
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies treatment 1 completed NCT03554434
An Expanded Access Program for AM0010 (Pegilodecakin) Not Available Not Available no_longer_available NCT03302234
Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598) treatment 3 completed NCT02938624
Anti PD-1 Neo-adjuvant Treatment for NSCLC treatment 1 completed NCT03727724
Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung Cancer treatment 2 completed NCT00092924
Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02128724
Palliative Thoracic Radiotherapy Plus BKM120 treatment 1 completed NCT00637624
N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy prevention Not Available terminated NCT00263016
Docetaxel in Non Small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT05703516
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea No drug interventions Not Available Not Available recruiting NCT06380816
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer No drug interventions treatment 1 / 2 recruiting NCT02483416
Evaluation of the Impact of Nurse-led Telephone on Treatment Compliance No drug interventions Not Available Not Available terminated NCT02014116
A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body No drug interventions treatment 1 terminated NCT04919616
An Exploratory Clinical Study of TILs in the Treatment of Recurrent / Refractory Non-small Cell Lung Cancer (NSCLC) No drug interventions treatment 0 not_yet_recruiting NCT03489616
Chemotherapy Combination With Local Radiotherapy and rhGM-CSF for Oligometastatic Stage IV NSCLC Patients treatment Not Available unknown_status NCT05440916
Palliative RadIotherapy of Multiple Metastatic Sites Before First Line of Systemic Therapy With Immune Checkpoint Inhibitors and Chemotherapy in Metastatic Non-Small-Cell Lung Cancer No drug interventions treatment 2 recruiting NCT01236716
Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung treatment 2 completed NCT02716116
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer treatment 1 / 2 active_not_recruiting NCT05110196
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC. treatment 4 recruiting NCT03957096
A Safety Study of SGN-CD47M in Patients With Solid Tumors No drug interventions treatment 1 terminated NCT06280196
A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC treatment 3 recruiting NCT02920996
Merestinib In Non-Small Cell Lung Cancer And Solid Tumors treatment 2 terminated NCT00199758
Study of an Early Change of a Chemotherapeutic Doublet Versus Four Cycles of Chemotherapy in Advanced Non Small Cell Lung Cancer treatment 2 completed NCT00527735
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) treatment 2 completed NCT04900935
Patient-centered, Optimal Integration of Survivorship and Palliative Care No drug interventions supportive_care Not Available recruiting NCT00690963
Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating No drug interventions treatment 1 / 2 unknown_status NCT00091663
A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 3 completed NCT03948763
A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001) treatment 1 completed NCT00191763
Neo-Adjuvant Gemcitabine and Cisplatin in Treating Patients With Early Stage of Non Small Cell Lung Cancer treatment 2 completed NCT03092986
Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer treatment 4 completed NCT02546986
Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT04925986
Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC treatment 2 terminated NCT00391586
Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung treatment 2 terminated NCT00473486
Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib treatment 1 / 2 terminated NCT00111839
Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer treatment 2 completed NCT00122239
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers No drug interventions Not Available Not Available unknown_status NCT02705339
Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC) treatment 2 withdrawn NCT03606239
NSCLC Isotoxic Hypofractionated Chemoradiotherapy No drug interventions treatment Not Available recruiting NCT01185639
Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer No drug interventions treatment Not Available completed NCT03092739
A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens No drug interventions Not Available Not Available completed NCT03498222
Study in Patients With Tumours Requiring Arginine to Assess ADI-PEG 20 With Atezolizumab, Pemetrexed and Carboplatin treatment 1 withdrawn NCT00059722
This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC. treatment 2 completed NCT00829322
Modafinil for the Treatment of Fatigue in Lung Cancer V9.0 treatment 4 completed NCT00558922
A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer treatment 1 / 2 terminated NCT05248022
Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure No drug interventions treatment Not Available not_yet_recruiting NCT03780725
This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 treatment 1 terminated NCT00095225
A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) treatment 2 completed NCT00730925
Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients treatment 2 completed NCT00532025
Sorafenib in Resected Non-small Cell Lung Carcinoma treatment 2 terminated NCT01288430
A Study of DS-2248 in Participants With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT01090830
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer other 1 / 2 terminated NCT00602030
Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC treatment 1 / 2 completed NCT01284348
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer supportive_care 2 terminated NCT00525148
LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations treatment 2 completed NCT04544748
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies No drug interventions treatment 1 active_not_recruiting NCT00545948
Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer treatment 2 terminated NCT04838548
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer treatment 2 unknown_status NCT00067548
Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer treatment 2 completed NCT02862457
Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434) treatment 1 completed NCT02810457
Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer treatment 3 completed NCT00509457
GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC) treatment Not Available completed NCT00230126
OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer treatment 2 completed NCT00005666
Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer No drug interventions treatment Not Available completed NCT02897765
A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer treatment 1 completed NCT05319574
SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT02039674
A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021) treatment 1 / 2 completed NCT05937074
Metabolic Response to Food in Lung Cancer No drug interventions Not Available Not Available recruiting NCT06282874
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases treatment 4 not_yet_recruiting NCT03381274
Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study treatment 1 / 2 active_not_recruiting NCT03950674
Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)-Japan Extension Study treatment 3 completed NCT03565120
Aggressive Thoracic Radiotherapy for Stage Ⅳ Non Small Cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT00798720
Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer treatment 2 completed NCT02475720
Survey on the Treatment Reality of Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Non-small Cell Lung Cancer(NSCLC) No drug interventions Not Available Not Available completed NCT00191620
Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer. treatment 2 completed NCT01079520
Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC) No drug interventions diagnostic Not Available completed NCT01683682
An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2) treatment 1 completed NCT01700582
French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings No drug interventions Not Available Not Available completed NCT01717482
Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer prevention 2 terminated NCT00759382
Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study. No drug interventions Not Available Not Available unknown_status NCT03563482
Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy. No drug interventions diagnostic Not Available unknown_status NCT00464282
Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer No drug interventions Not Available Not Available completed NCT04737382
Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. No drug interventions diagnostic Not Available recruiting NCT05805631
Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC treatment 2 not_yet_recruiting NCT00263731
Metabolomic Analysis of Lung Cancer No drug interventions Not Available Not Available completed NCT00768131
A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel Not Available 2 withdrawn NCT03030131
Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer treatment 2 terminated NCT02000531
Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population treatment 4 completed NCT03996473
Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases treatment 1 terminated NCT02094573
A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib treatment 2 completed NCT05462873
A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01999673
Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer treatment 3 completed NCT04944173
SCION: SABR and Checkpoint Inhibition of NSCLC treatment 2 withdrawn NCT00946673
Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer treatment 1 completed NCT00560573
Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer treatment 1 completed NCT02209727
Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer treatment 1 terminated NCT00861627
Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation treatment 2 completed NCT04051827
Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) other 1 completed NCT00034827
A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer treatment 2 completed NCT01637376
Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer treatment 1 withdrawn NCT00934076
Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer treatment 1 withdrawn NCT00910676
Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors prevention 2 completed NCT04611776
A Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezolizumab, in Patients Who Are ctDNA Positive After Complete Surgical Resection of Stage IB to Select IIIB Non-Small Cell Lung Cancer treatment 2 withdrawn NCT02934360
TR(ACE) Assay Clinical Specimen Study No drug interventions Not Available Not Available unknown_status NCT00876460
BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I treatment 1 completed NCT03108560
Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer No drug interventions treatment Not Available unknown_status NCT00697060
A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer treatment 2 withdrawn NCT06281860
Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration No drug interventions treatment 1 recruiting NCT00112294
Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer treatment 3 completed NCT00805194
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer treatment 3 completed NCT03799094
Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations treatment 1 / 2 unknown_status NCT02824094
Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC Not Available Not Available no_longer_available NCT02864394
Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033) treatment 3 completed NCT00635791
Phase I Study of Vorinostat and Sorafenib in Advanced Cancer treatment 1 completed NCT02161991
Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers treatment 3 completed NCT02554591
Genomic Landscape of Ceritinib No drug interventions Not Available Not Available terminated NCT03606291
NSCLC Isotoxic Hypofractionated Radiotherapy No drug interventions treatment Not Available recruiting NCT03083691
BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer treatment 2 completed NCT02799862
Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC Not Available Not Available completed NCT05869162
Phase II Study of SY-3505 in Patients With ALK-positive NSCLC Who Have Failed Prior Second-Generation ALK TKI treatment 2 recruiting NCT03872362
Radiomics Multifactorial Biomarker for Pulmonary Nodules No drug interventions Not Available Not Available completed NCT00130780
Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC treatment 2 completed NCT00124280
Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02578680
Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189) treatment 3 completed NCT02693080
CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy diagnostic 1 completed NCT02044380
Afatinib in Patients With Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Mutations treatment 3 completed NCT05544929
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers treatment 1 recruiting NCT06127329
Efficacy and Safety of BAI Combined With DEB-BACE of EqualSpheres in the Treatment of Advanced NSCLC No drug interventions treatment Not Available not_yet_recruiting NCT00192829
Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma No drug interventions Not Available Not Available unknown_status NCT00256789
Once Weekly Radiation for Lung Cancer With Chemotherapy No drug interventions treatment Not Available completed NCT01382992
A Retrospective EGFR Mutation Status Study in Chinese NSCLC Patients Using Paired Plasma and Tissue Samples No drug interventions Not Available Not Available unknown_status NCT03884192
Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC treatment 3 unknown_status NCT00457392
A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone treatment 3 completed NCT00105092
Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. treatment 2 completed NCT00129844
Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer treatment 2 completed NCT00071344
Analysis of Brain Metastasis in Patients With Lung Cancer No drug interventions Not Available Not Available completed NCT01167244
Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response treatment 2 completed NCT01160744
A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02650544
Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression treatment 2 unknown_status NCT03057340
The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells No drug interventions treatment 1 unknown_status NCT01761240
Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC treatment 1 completed NCT00080340
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer treatment 3 completed NCT01346540
A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology. treatment 1 completed NCT00536640
Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab treatment 2 completed NCT02492867
A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer treatment Not Available completed NCT01326767
Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring treatment 3 completed NCT01307267
A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab treatment 1 completed NCT04042701
DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer treatment 1 recruiting NCT03761901
Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium No drug interventions Not Available Not Available completed NCT00905801
Computed Tomography (CT) Perfusion Imaging of Lung Cancer No drug interventions diagnostic Not Available terminated NCT03212404
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers treatment 1 recruiting NCT03724604
NSE/Alb as a Prognostic Biomarker for Lung Cancer No drug interventions Not Available Not Available unknown_status NCT02705404
A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing No drug interventions Not Available Not Available terminated NCT02395172
Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) treatment 3 completed NCT02848872
Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT01199068
CS-7017 in Combination With Erlotinib in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC) treatment 1 completed NCT00086268
Non-small Cell Lung Cancer Study US75 (Z-PACT) prevention 3 completed NCT00633568
Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer treatment 3 terminated NCT01891669
A Study Of PF-06263507 In Patients With Advanced Solid Tumors No drug interventions treatment 1 terminated NCT03712969
Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC treatment 4 completed NCT03849469
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors treatment 1 completed NCT03085069
A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC treatment 2 active_not_recruiting NCT01652469
Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®. treatment 3 completed NCT04956146
Fruquintinib Combined With Sintilimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer treatment 2 recruiting NCT00061646
Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC) treatment 2 terminated NCT02172846
Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer treatment 1 completed NCT00824746
Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC) treatment 2 completed NCT02332512
Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR) treatment 3 unknown_status NCT00129012
Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer No drug interventions treatment 1 completed NCT03509012
Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors treatment 1 active_not_recruiting NCT05321212
Efficacy and Safety of PEMbrolizumab PD-L1-positive (>50% of Tumor Cells), Advanced NSCL Cancer(PEMBREIZH) No drug interventions Not Available Not Available completed NCT04023812
Stage III NSCLC RWE in Chinese Patients No drug interventions Not Available Not Available completed NCT04115410
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study Not Available Not Available unknown_status NCT02271581
Effect of Symptom Management on Inflammation and Survival in Metastatic Lung Cancer No drug interventions Not Available Not Available completed NCT00923481
A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... treatment 2 completed NCT00148395
Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. treatment 3 completed NCT00054795
Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) treatment 3 completed NCT03321695
A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in Argentina No drug interventions Not Available Not Available completed NCT00540514
Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer treatment 3 completed NCT02499614
Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS) treatment 2 unknown_status NCT04816214
Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy treatment 3 terminated NCT03156114
This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment. treatment 1 completed NCT04452214
A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors treatment 1 completed NCT00078455
Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma No drug interventions treatment 2 completed NCT01199055
CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC) treatment 1 completed NCT00001450
Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC treatment 2 completed NCT02182050
Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer treatment 2 completed NCT03623750
E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C treatment 1 / 2 completed NCT00290550
A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006) No drug interventions treatment 2 terminated NCT01229150
Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With Erlotinib in KRAS Wild Type Advanced Non-Small Cell Lung Cancer (NSCLC) and a Randomized Phase II Study of AZD6244 With Erlotinib in Mutant KRAS Adva... treatment 2 completed NCT01209650
LUX Lung Special Access Scheme Australia Named Patient Use (NPU) Not Available Not Available approved_for_marketing NCT01255150
Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT01064050
Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers No drug interventions treatment 4 terminated NCT00271323
Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients treatment 2 terminated NCT03023423
A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer treatment 1 / 2 completed NCT00376623
Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer treatment 2 completed NCT04995523
A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC treatment 1 / 2 active_not_recruiting NCT02743923
Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer treatment 3 unknown_status NCT02018523
Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer treatment 1 terminated NCT05566223
CISH Inactivated TILs in the Treatment of NSCLC treatment 1 / 2 not_yet_recruiting NCT03904108
Platinum-Based Chemotherapy Plus Ramucirumab in Patients With Advanced NSCLC Who Have Progressed on First Line Anti-PD-1 Immunotherapy treatment 2 terminated NCT05153408
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC treatment 1 terminated NCT05644808
MYLUNG Consortium Study Protocol 2 No drug interventions Not Available Not Available active_not_recruiting NCT00321308
Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer treatment 2 terminated NCT05525338
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels treatment 4 recruiting NCT06461338
Acupuncture for Enhancing Immunotherapy in Advanced NSCLC：a Pilot Study No drug interventions treatment Not Available not_yet_recruiting NCT01674738
TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV treatment 2 withdrawn NCT03054038
Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer treatment 1 terminated NCT00603538
Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer treatment 1 completed NCT02716038
Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC treatment 2 completed NCT01999738
Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors treatment 1 completed NCT00797238
DNA Repair Genes and Outcomes in Patients With Stage III NSCLC No drug interventions Not Available Not Available unknown_status NCT02298153
A Study of Atezolizumab (MPDL3280A) in Combination With Epacadostat (INCB024360) in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer and Previously Treated Stage IV Urothelial Carcinoma (ECHO-110) treatment 1 terminated NCT02257619
Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer treatment 2 terminated NCT02355431
Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations treatment 2 withdrawn NCT02119650
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer treatment 2 terminated NCT02542293
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) treatment 3 active_not_recruiting NCT03003962
Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL) treatment 3 active_not_recruiting NCT00735904
Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer treatment 2 completed NCT04187872
LITT and Pembrolizumab in Recurrent Brain Metastasis treatment 1 terminated NCT02346955
Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001) treatment 1 terminated NCT02558998
Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care No drug interventions supportive_care Not Available completed NCT04256707
Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment treatment 1 / 2 recruiting NCT02453282
Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) treatment 3 active_not_recruiting NCT00328562
ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer treatment 1 completed NCT04460729
A Phase II, Open-Label, Multicenter Study of Capmatinib in Subjects With MET Exon 14 Skipping Mutation Positive, Advanced, NSCLC With Brain Metastases treatment 2 withdrawn NCT03128008
Locally Advanced NSCLC Hyperfractionated RT treatment 2 completed NCT04214262
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer treatment 3 active_not_recruiting NCT04267848
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial treatment 3 recruiting NCT04314401
National Cancer Institute "Cancer Moonshot Biobank" No drug interventions Not Available Not Available recruiting NCT04929041
Testing the Addition of Radiation Therapy to Immunotherapy for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative treatment 2 / 3 recruiting NCT05672108
Transarterial Chemoembolization for the Treatment of Lung Cancer and Lung Metastases treatment 2 recruiting NCT04836429
Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease treatment 1 active_not_recruiting NCT05242965
A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer treatment 2 recruiting NCT06418204
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics No drug interventions Not Available Not Available not_yet_recruiting NCT06427369
An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer No drug interventions diagnostic 1 withdrawn NCT06122064
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer No drug interventions health_services_research Not Available recruiting NCT02715102
Circulating Tumor DNA in Patients at High Risk for Lung Cancer No drug interventions Not Available Not Available terminated NCT04946279
Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer No drug interventions health_services_research Not Available active_not_recruiting NCT03410043
Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study treatment 2 active_not_recruiting NCT04625647
Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) treatment 2 recruiting NCT04407247
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma treatment 1 / 2 recruiting NCT04073745
Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer No drug interventions treatment 1 recruiting NCT05364645
Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer treatment 2 withdrawn NCT05416983
Developing a Shared Decision Making Tool for Patients With Surgically Removed Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT04913311
Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer No drug interventions Not Available Not Available recruiting NCT05304793
Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer No drug interventions supportive_care Not Available completed NCT06438588
Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial No drug interventions supportive_care Not Available recruiting NCT05340309
Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer treatment 2 recruiting NCT04289259
Tumor Mutational Burden in Lung Cancer Patients No drug interventions Not Available Not Available terminated NCT05801406
From Benchmark to Surgical Activity: the Role of Endobronchial Fiducial Markers for Ground Glass Lung Nodules Resection. No drug interventions Not Available Not Available not_yet_recruiting NCT04032418
Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung Cancer treatment 2 active_not_recruiting NCT03634241
Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study prevention 2 recruiting NCT03637816
Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer supportive_care 2 / 3 active_not_recruiting NCT05830058
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma No drug interventions treatment 2 recruiting NCT06498635
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial treatment 3 not_yet_recruiting NCT04705025
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer No drug interventions supportive_care Not Available terminated NCT03707925
Bronchoscopic Laser Ablation of Peripheral Lung Tumors No drug interventions diagnostic Not Available terminated NCT05493566
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer treatment 0 recruiting NCT05501665
Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer treatment 1 / 2 suspended NCT06116682
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial) treatment 2 not_yet_recruiting NCT06014827
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) With Osimertinib for the Treatment of Patients With Oligoprogressive EGFR Positive Non-small Cell Lung Carcinoma treatment 2 recruiting NCT05022394
Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study treatment 1 / 2 withdrawn NCT04262869
Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer treatment 2 withdrawn NCT04694846
Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use prevention Not Available active_not_recruiting NCT04987281
Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study device_feasibility 2 withdrawn NCT04085081
Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers No drug interventions supportive_care Not Available withdrawn NCT03707938
Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer treatment 1 active_not_recruiting NCT02955290
CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer treatment 1 / 2 recruiting NCT04061590
Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer treatment 2 withdrawn NCT05292521
Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer No drug interventions health_services_research Not Available recruiting NCT05717998
Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy No drug interventions Not Available Not Available recruiting NCT04428905
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT04989283
Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer treatment 2 withdrawn NCT03546361
CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer treatment 1 active_not_recruiting NCT05443971
Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen treatment 2 recruiting NCT02983578
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer treatment 2 active_not_recruiting NCT06265285
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program health_services_research 2 recruiting NCT03948100
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers No drug interventions supportive_care Not Available recruiting NCT05412875
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung supportive_care Not Available withdrawn NCT04013542
Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer treatment 1 active_not_recruiting NCT04298606
A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence prevention 0 recruiting NCT03819296
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer treatment 1 / 2 recruiting NCT05802186
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study No drug interventions treatment Not Available recruiting NCT04430725
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study No drug interventions Not Available Not Available recruiting NCT03944265
Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung Cancer No drug interventions supportive_care Not Available completed NCT05106374
Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer No drug interventions Not Available Not Available unknown_status NCT06139627
Evaluation of Geriatric Assessment and Management for Older Adults With Non-small Cell Lung Cancer Receiving Chemotherapy Radiation Therapy No drug interventions supportive_care Not Available recruiting NCT06225427
Gilteritinib for the Treatment of ALK NSCLC treatment 1 recruiting NCT03824327
Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases treatment 1 suspended NCT04348292
Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer treatment 1 terminated NCT04005144
Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung Cancer treatment 1 terminated NCT05740501
Pharmacokinetic Profiling of Pembrolizumab and Nivolumab in Patients With Melanoma and/or Non-Small Cell Lung Cancer No drug interventions Not Available Not Available completed NCT03391869
Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer treatment 3 recruiting NCT03939481
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05502523
The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer No drug interventions treatment Not Available suspended